EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 200 filers reported holding EDITAS MEDICINE INC in Q1 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $92,000 | -78.3% | 2,250 | -70.0% | 0.00% | -100.0% |
| Q2 2021 | $424,000 | +34.2% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $316,000 | -85.1% | 7,500 | +36.4% | 0.00% | 0.0% |
| Q4 2020 | $2,121,000 | +798.7% | 5,500 | -34.5% | 0.00% | 0.0% |
| Q3 2020 | $236,000 | -4.8% | 8,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $248,000 | +86.5% | 8,400 | +25.4% | 0.00% | 0.0% |
| Q1 2020 | $133,000 | -32.8% | 6,700 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $198,000 | +760.9% | 6,700 | +556.9% | 0.00% | – |
| Q3 2019 | $23,000 | -76.8% | 1,020 | -74.5% | 0.00% | -100.0% |
| Q2 2019 | $99,000 | +1.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $98,000 | +172.2% | 4,000 | +150.0% | 0.00% | – |
| Q4 2018 | $36,000 | -29.4% | 1,600 | 0.0% | 0.00% | – |
| Q3 2018 | $51,000 | -10.5% | 1,600 | 0.0% | 0.00% | – |
| Q2 2018 | $57,000 | +7.5% | 1,600 | 0.0% | 0.00% | – |
| Q1 2018 | $53,000 | +8.2% | 1,600 | 0.0% | 0.00% | – |
| Q4 2017 | $49,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |